OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 126 filers reported holding OCULAR THERAPEUTIX INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $546,884 | -47.2% | 174,167 | -13.3% | 0.01% | -58.3% |
| Q2 2023 | $1,036,350 | +287775.0% | 200,843 | +193.7% | 0.01% | +100.0% |
| Q1 2023 | $360 | +29.0% | 68,384 | -31.2% | 0.01% | 0.0% |
| Q4 2022 | $279 | -99.9% | 99,338 | +60.8% | 0.01% | 0.0% |
| Q3 2022 | $256,000 | +24.9% | 61,775 | +21.0% | 0.01% | +20.0% |
| Q2 2022 | $205,000 | -28.3% | 51,039 | +24.5% | 0.01% | 0.0% |
| Q4 2021 | $286,000 | -69.8% | 40,987 | -56.7% | 0.01% | -66.7% |
| Q3 2021 | $947,000 | +695.8% | 94,712 | +645.8% | 0.02% | +400.0% |
| Q4 2015 | $119,000 | -67.9% | 12,700 | -28.1% | 0.00% | -72.7% |
| Q2 2015 | $371,000 | – | 17,663 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 5,618,861 | $116,310,000 | 100.00% |
| Opaleye Management Inc. | 6,510,000 | $134,758,000 | 17.60% |
| DELTEC ASSET MANAGEMENT LLC | 2,168,573 | $44,889,000 | 6.87% |
| Versant Venture Management, LLC | 1,465,384 | $30,333,000 | 3.15% |
| GREAT POINT PARTNERS LLC | 856,162 | $17,723,000 | 2.88% |
| Affinity Asset Advisors, LLC | 220,000 | $4,554,000 | 2.41% |
| Altium Capital Management LP | 303,174 | $6,276,000 | 2.34% |
| Endurant Capital Management LP | 290,465 | $6,013,000 | 2.17% |
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 50,396 | $1,043,000 | 1.17% |
| Lisanti Capital Growth, LLC | 366,040 | $7,577,000 | 1.05% |